Project
Illumina Body Map 2
Navigation
Downloads
Results for TCF12_ASCL2
Z-value: 2.16
Motif logo
Transcription factors associated with TCF12_ASCL2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TCF12
|
ENSG00000140262.13 | transcription factor 12 |
|
ASCL2
|
ENSG00000183734.4 | achaete-scute family bHLH transcription factor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ASCL2 | hg19_v2_chr11_-_2292182_2292212 | 0.19 | 2.9e-01 | Click! |
| TCF12 | hg19_v2_chr15_+_57211318_57211355 | -0.18 | 3.3e-01 | Click! |
Activity profile of TCF12_ASCL2 motif
Sorted Z-values of TCF12_ASCL2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_39258461 | 8.43 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
| chr22_+_22730353 | 8.29 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
| chr16_+_23847267 | 8.27 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr1_+_27668505 | 7.01 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
| chr16_+_23847339 | 7.01 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr5_-_176936844 | 6.66 |
ENST00000510380.1
ENST00000510898.1 ENST00000357198.4 |
DOK3
|
docking protein 3 |
| chr22_-_37882395 | 6.40 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr22_+_22707260 | 6.38 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr16_+_23847355 | 6.10 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chr5_-_176936817 | 5.64 |
ENST00000502885.1
ENST00000506493.1 |
DOK3
|
docking protein 3 |
| chr2_+_90273679 | 5.60 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr21_-_46330545 | 5.46 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr11_+_128634589 | 5.45 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr14_-_107114267 | 5.41 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr17_+_34538310 | 5.41 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
| chr14_-_106781017 | 5.37 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr15_+_89182178 | 5.31 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr17_-_39296739 | 5.28 |
ENST00000345847.4
|
KRTAP4-6
|
keratin associated protein 4-6 |
| chr2_-_89278535 | 5.26 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr16_+_32077386 | 5.22 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr2_-_89327228 | 5.17 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr14_-_106791536 | 5.14 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
| chr15_+_89182156 | 5.06 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr15_+_89181974 | 5.03 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr2_-_90538397 | 5.00 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr22_+_23241661 | 4.95 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr22_+_23029188 | 4.89 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr2_+_90259593 | 4.85 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
| chr16_-_89043377 | 4.76 |
ENST00000436887.2
ENST00000448839.1 ENST00000360302.2 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr14_-_106692191 | 4.67 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr14_-_107211459 | 4.65 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr14_-_106878083 | 4.63 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr6_-_24911195 | 4.61 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr2_+_87565634 | 4.52 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr14_-_106322288 | 4.49 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr17_-_39274606 | 4.48 |
ENST00000391413.2
|
KRTAP4-11
|
keratin associated protein 4-11 |
| chr20_+_44637526 | 4.45 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| chr17_-_39280419 | 4.32 |
ENST00000394014.1
|
KRTAP4-12
|
keratin associated protein 4-12 |
| chr20_+_37434329 | 4.20 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
| chr17_+_34431212 | 4.19 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
| chr2_+_90211643 | 4.15 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr17_+_34639793 | 4.13 |
ENST00000394465.2
ENST00000394463.2 ENST00000378342.4 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
| chr20_+_62367989 | 4.10 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
| chr5_-_94620239 | 3.95 |
ENST00000515393.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
| chr2_-_235405168 | 3.93 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr2_-_158345462 | 3.91 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr1_-_92951607 | 3.89 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
| chr10_-_98480243 | 3.89 |
ENST00000339364.5
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
| chr14_-_106586656 | 3.81 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr14_-_107170409 | 3.76 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr19_-_7764960 | 3.74 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr11_+_60223312 | 3.71 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr1_+_206680879 | 3.69 |
ENST00000355294.4
ENST00000367117.3 |
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
| chr17_+_34430980 | 3.68 |
ENST00000250151.4
|
CCL4
|
chemokine (C-C motif) ligand 4 |
| chr14_-_106805716 | 3.63 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
| chr4_+_154387480 | 3.58 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr17_+_34640031 | 3.52 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
| chr22_+_22697537 | 3.52 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr10_-_73848531 | 3.47 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr21_+_10862622 | 3.45 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr10_-_73848764 | 3.42 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr11_+_60223225 | 3.37 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr20_+_3776936 | 3.35 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
| chr7_+_2687173 | 3.34 |
ENST00000403167.1
|
TTYH3
|
tweety family member 3 |
| chr14_-_106725723 | 3.34 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr4_+_74718906 | 3.32 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr22_+_24823517 | 3.31 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
| chr11_-_441964 | 3.29 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
| chr3_-_71834318 | 3.25 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
| chr6_+_42883727 | 3.23 |
ENST00000304672.1
ENST00000441198.1 ENST00000446507.1 |
PTCRA
|
pre T-cell antigen receptor alpha |
| chr1_-_169680745 | 3.22 |
ENST00000236147.4
|
SELL
|
selectin L |
| chr19_+_7733929 | 3.19 |
ENST00000221515.2
|
RETN
|
resistin |
| chr1_-_27961720 | 3.17 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr21_+_30503282 | 3.16 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr1_-_207096529 | 3.15 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr14_-_106471723 | 3.15 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr15_+_74833518 | 3.10 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr11_+_45944190 | 3.07 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr14_-_106967788 | 3.05 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr22_+_23247030 | 3.04 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr2_+_90121477 | 3.02 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr11_+_117857063 | 2.98 |
ENST00000227752.3
ENST00000541785.1 ENST00000545409.1 |
IL10RA
|
interleukin 10 receptor, alpha |
| chr14_-_106539557 | 2.97 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr2_-_87017985 | 2.96 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
| chr17_-_39191107 | 2.95 |
ENST00000344363.5
|
KRTAP1-3
|
keratin associated protein 1-3 |
| chr16_-_11485922 | 2.94 |
ENST00000599216.1
|
CTD-3088G3.8
|
Protein LOC388210 |
| chr2_+_218994002 | 2.92 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr22_-_24181174 | 2.91 |
ENST00000318109.7
ENST00000406855.3 ENST00000404056.1 ENST00000476077.1 |
DERL3
|
derlin 3 |
| chr16_-_89043605 | 2.90 |
ENST00000268679.4
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr7_+_12726623 | 2.90 |
ENST00000439721.1
|
ARL4A
|
ADP-ribosylation factor-like 4A |
| chr16_-_31076332 | 2.90 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
| chr2_-_158295915 | 2.89 |
ENST00000418920.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr19_+_17638059 | 2.88 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
| chr14_-_106668095 | 2.88 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
| chr14_-_107131560 | 2.87 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr6_+_31540056 | 2.86 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
| chr14_-_107219365 | 2.86 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr7_+_50344289 | 2.85 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr2_-_87017948 | 2.85 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
| chr11_+_1892102 | 2.83 |
ENST00000417766.1
|
LSP1
|
lymphocyte-specific protein 1 |
| chr2_-_89292422 | 2.82 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr14_-_106114739 | 2.81 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr2_-_89619904 | 2.80 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr16_+_67679069 | 2.79 |
ENST00000545661.1
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
| chr6_-_32731243 | 2.78 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr9_-_117150243 | 2.76 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr21_+_30502806 | 2.74 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr7_+_142494038 | 2.73 |
ENST00000390412.1
|
TRBJ2-1
|
T cell receptor beta joining 2-1 |
| chr9_-_35619539 | 2.72 |
ENST00000396757.1
|
CD72
|
CD72 molecule |
| chrX_+_71354000 | 2.72 |
ENST00000510661.1
ENST00000535692.1 |
NHSL2
|
NHS-like 2 |
| chr17_+_76165213 | 2.72 |
ENST00000590201.1
|
SYNGR2
|
synaptogyrin 2 |
| chrX_+_123480194 | 2.72 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
| chr15_-_22448819 | 2.70 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr6_-_31550192 | 2.69 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr2_-_89442621 | 2.69 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr4_+_102268904 | 2.66 |
ENST00000527564.1
ENST00000529296.1 |
AP001816.1
|
Uncharacterized protein |
| chr22_+_22723969 | 2.64 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr16_-_89043488 | 2.63 |
ENST00000563640.1
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr1_+_207627575 | 2.63 |
ENST00000367058.3
ENST00000367057.3 ENST00000367059.3 |
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
| chr20_+_62369623 | 2.63 |
ENST00000467211.1
|
RP4-583P15.14
|
RP4-583P15.14 |
| chr6_-_41122063 | 2.62 |
ENST00000426005.2
ENST00000437044.2 ENST00000373127.4 |
TREML1
|
triggering receptor expressed on myeloid cells-like 1 |
| chr2_+_90198535 | 2.61 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr2_-_158345341 | 2.60 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr19_+_17865011 | 2.59 |
ENST00000596462.1
ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1
|
FCH domain only 1 |
| chr16_+_32063311 | 2.58 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr2_+_69002052 | 2.58 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr14_-_106830057 | 2.57 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr6_-_32731299 | 2.57 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr1_+_28206150 | 2.56 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
| chr19_-_48547294 | 2.56 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
| chr22_+_23089870 | 2.56 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr2_+_89923550 | 2.53 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr20_+_48884002 | 2.52 |
ENST00000425497.1
ENST00000445003.1 |
RP11-290F20.3
|
RP11-290F20.3 |
| chr1_+_156119798 | 2.52 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr22_+_22385332 | 2.50 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr7_-_3083472 | 2.50 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr14_+_22386325 | 2.45 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr19_+_35634146 | 2.44 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
| chr2_+_89184868 | 2.43 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr22_+_22516550 | 2.42 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr22_+_23010756 | 2.42 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
| chr17_+_80193644 | 2.41 |
ENST00000582946.1
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
| chr16_+_81772633 | 2.40 |
ENST00000566191.1
ENST00000565272.1 ENST00000563954.1 ENST00000565054.1 |
RP11-960L18.1
PLCG2
|
RP11-960L18.1 phospholipase C, gamma 2 (phosphatidylinositol-specific) |
| chr22_-_50970506 | 2.38 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr19_+_55085248 | 2.38 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr2_-_197036289 | 2.38 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
| chr5_-_176326333 | 2.37 |
ENST00000292432.5
|
HK3
|
hexokinase 3 (white cell) |
| chr14_+_21359558 | 2.37 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
| chr7_-_3083573 | 2.36 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr17_-_46262541 | 2.36 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
| chr16_-_88772670 | 2.36 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
| chr22_+_23222886 | 2.35 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr4_-_165305086 | 2.34 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
| chr16_-_88772761 | 2.32 |
ENST00000567844.1
ENST00000312838.4 |
RNF166
|
ring finger protein 166 |
| chr3_+_122296443 | 2.32 |
ENST00000464300.2
|
PARP15
|
poly (ADP-ribose) polymerase family, member 15 |
| chr12_+_6554021 | 2.31 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
| chr1_-_202129704 | 2.31 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr15_-_40600111 | 2.31 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
| chr10_-_103347883 | 2.30 |
ENST00000339310.3
ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL
|
polymerase (DNA directed), lambda |
| chr2_-_89247338 | 2.29 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr17_+_76164639 | 2.29 |
ENST00000225777.3
ENST00000585591.1 ENST00000589711.1 ENST00000588282.1 ENST00000589168.1 |
SYNGR2
|
synaptogyrin 2 |
| chr14_-_106963409 | 2.29 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chrX_-_118827333 | 2.29 |
ENST00000360156.7
ENST00000354228.4 ENST00000489216.1 ENST00000354416.3 ENST00000394610.1 ENST00000343984.5 |
SEPT6
|
septin 6 |
| chr13_+_108922228 | 2.28 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
| chr3_-_27763803 | 2.27 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
| chr2_-_89340242 | 2.26 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr22_+_23264766 | 2.26 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr1_+_32716857 | 2.26 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr12_-_2027639 | 2.25 |
ENST00000586184.1
ENST00000587995.1 ENST00000585732.1 |
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
| chr5_+_56111361 | 2.24 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr2_+_114163945 | 2.24 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr12_-_109027643 | 2.23 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
| chr9_+_129622904 | 2.23 |
ENST00000319119.4
|
ZBTB34
|
zinc finger and BTB domain containing 34 |
| chr2_+_219745020 | 2.23 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
| chrX_+_123480375 | 2.21 |
ENST00000360027.4
|
SH2D1A
|
SH2 domain containing 1A |
| chr17_+_39261584 | 2.21 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
| chr16_+_29674277 | 2.21 |
ENST00000395389.2
|
SPN
|
sialophorin |
| chr12_-_53074182 | 2.21 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
| chr22_+_37678424 | 2.20 |
ENST00000248901.6
|
CYTH4
|
cytohesin 4 |
| chrX_+_129305623 | 2.20 |
ENST00000257017.4
|
RAB33A
|
RAB33A, member RAS oncogene family |
| chr16_+_57576584 | 2.19 |
ENST00000340339.4
|
GPR114
|
G protein-coupled receptor 114 |
| chr19_+_42381173 | 2.19 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr3_-_71834207 | 2.18 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
| chr12_-_53601000 | 2.18 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
| chr17_+_7239821 | 2.18 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr1_+_156119466 | 2.18 |
ENST00000414683.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr2_-_87018784 | 2.17 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr2_+_90139056 | 2.17 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr22_-_37608325 | 2.16 |
ENST00000328544.3
|
SSTR3
|
somatostatin receptor 3 |
| chr1_+_32716840 | 2.15 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr7_+_128784712 | 2.15 |
ENST00000289407.4
|
TSPAN33
|
tetraspanin 33 |
| chr17_+_43299241 | 2.14 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr19_+_42381337 | 2.14 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr11_+_118215036 | 2.13 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
| chr22_+_23134974 | 2.13 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr16_+_12058961 | 2.13 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
| chr17_+_7239904 | 2.13 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr4_+_40198527 | 2.12 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
| chr20_+_57766075 | 2.12 |
ENST00000371030.2
|
ZNF831
|
zinc finger protein 831 |
| chr14_+_22554680 | 2.12 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TCF12_ASCL2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.4 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 3.1 | 15.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.7 | 10.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 1.6 | 8.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.4 | 4.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.4 | 4.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.3 | 3.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.2 | 8.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.2 | 1.2 | GO:0019724 | B cell mediated immunity(GO:0019724) |
| 1.1 | 3.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.1 | 6.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.1 | 3.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 1.1 | 4.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.1 | 3.2 | GO:2000870 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
| 0.9 | 76.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.9 | 3.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.9 | 4.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 3.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.8 | 2.4 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.8 | 3.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 | 10.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.7 | 3.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.7 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.7 | 2.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.7 | 2.7 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.7 | 4.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.6 | 4.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.6 | 3.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.6 | 0.6 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.6 | 76.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.6 | 0.6 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.6 | 3.1 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.6 | 0.6 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
| 0.6 | 1.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.6 | 3.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.6 | 1.8 | GO:1904346 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.6 | 2.4 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.6 | 1.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.6 | 1.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.5 | 3.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.5 | 3.7 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.5 | 1.6 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.5 | 1.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 2.0 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.5 | 7.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.5 | 0.5 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
| 0.5 | 8.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.5 | 1.5 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.5 | 1.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.5 | 1.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.4 | 3.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.4 | 93.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.4 | 8.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.4 | 0.4 | GO:0072608 | interleukin-10 secretion(GO:0072608) |
| 0.4 | 2.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.4 | 2.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.4 | 1.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.4 | 4.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.4 | 0.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.4 | 0.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.4 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.4 | 10.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.4 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
| 0.4 | 1.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.4 | 1.2 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.4 | 1.1 | GO:1903980 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) positive regulation of microglial cell activation(GO:1903980) |
| 0.4 | 1.9 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 0.8 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.4 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) leukocyte migration involved in immune response(GO:0002522) |
| 0.4 | 3.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.4 | 1.1 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 | 1.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.4 | 1.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.4 | 0.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.4 | 2.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.4 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.1 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.3 | 2.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.3 | 1.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.3 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 1.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 | 1.3 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.3 | 1.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 2.0 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.3 | 1.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.3 | 1.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.3 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 1.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 | 1.0 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.3 | 1.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.3 | 1.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.3 | 3.2 | GO:0050867 | positive regulation of cell activation(GO:0050867) |
| 0.3 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 3.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 1.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 | 0.6 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
| 0.3 | 1.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.3 | 0.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.3 | 4.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.3 | 4.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 0.9 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.3 | 0.9 | GO:1900369 | transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
| 0.3 | 0.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 | 1.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.3 | 0.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.3 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 | 1.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 1.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.3 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 1.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.3 | 1.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 1.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.3 | 3.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.3 | 1.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.3 | 1.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.3 | 1.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.3 | 1.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 1.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 0.8 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 1.5 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 | 2.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 0.5 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.3 | 0.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 | 2.0 | GO:0015755 | fructose transport(GO:0015755) |
| 0.2 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.2 | 4.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 7.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 1.7 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.2 | 1.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 3.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 0.7 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.2 | 1.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 5.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 1.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.2 | 1.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.2 | 3.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 4.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 | 0.7 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.2 | 0.7 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 | 0.7 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.2 | 0.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.2 | 4.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 1.4 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.2 | 1.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.2 | 2.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 2.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 | 0.2 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 2.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.2 | 0.7 | GO:0051714 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.2 | 1.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.2 | 1.1 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 | 0.6 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.2 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.2 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.2 | 13.5 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.2 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.2 | 1.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 2.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 5.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.2 | 2.5 | GO:0048003 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 1.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 | 6.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.2 | 1.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 15.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.2 | 1.0 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.2 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.2 | 4.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.2 | 1.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.2 | 1.7 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 3.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 0.6 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.2 | 3.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 1.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.2 | 0.6 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.2 | 1.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.2 | 3.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.2 | 2.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 1.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 1.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 2.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.2 | 0.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.2 | 0.5 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.2 | 1.1 | GO:0033563 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) dorsal/ventral axon guidance(GO:0033563) |
| 0.2 | 2.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 0.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 | 0.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 2.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.2 | 0.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 0.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 | 1.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.2 | 3.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 1.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 3.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.2 | 0.8 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.2 | 4.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 | 5.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 0.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 0.7 | GO:0061324 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.2 | 5.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 3.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.2 | 7.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.2 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.2 | 0.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 2.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 0.5 | GO:0010193 | response to ozone(GO:0010193) |
| 0.2 | 1.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.2 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.6 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.2 | 0.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.2 | 0.8 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.2 | 0.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.2 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 2.2 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.1 | 0.4 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.1 | 3.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.4 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 1.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 2.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 1.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 | 0.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 0.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.1 | 0.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.1 | 1.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 | 0.4 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.1 | 1.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 1.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.9 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 | 1.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 3.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.4 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 | 1.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.1 | 0.4 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.1 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 1.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.1 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 | 2.8 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 0.9 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.1 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.7 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.1 | 1.1 | GO:2000406 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
| 0.1 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 1.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.1 | GO:0060632 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of microtubule-based movement(GO:0060632) |
| 0.1 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 1.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 4.9 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 1.0 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.2 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 | 0.5 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 1.7 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
| 0.1 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.5 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.2 | GO:0042098 | T cell proliferation(GO:0042098) |
| 0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.1 | 0.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.1 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.5 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 3.6 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 | 1.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.1 | 0.5 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 1.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 0.7 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.1 | 2.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.3 | GO:0021940 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 5.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 21.5 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 0.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 1.1 | GO:0045088 | regulation of innate immune response(GO:0045088) |
| 0.1 | 1.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.1 | 1.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 4.2 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 2.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.1 | 2.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
| 0.1 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 1.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.1 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.1 | 6.7 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.6 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.1 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 | 1.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.1 | 0.2 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.1 | 1.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 1.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
| 0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.1 | 1.5 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
| 0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 | 1.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.5 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 1.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 1.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 1.3 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 1.7 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.1 | 0.4 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 1.0 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 1.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 4.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.1 | 0.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.1 | 0.3 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 | 2.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.3 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 1.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 1.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.1 | 0.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
| 0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.1 | 0.4 | GO:0061738 | vacuolar transmembrane transport(GO:0034486) late endosomal microautophagy(GO:0061738) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.1 | 4.6 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 1.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.1 | 1.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 0.1 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 0.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.1 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 0.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 0.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.5 | GO:0006260 | DNA replication(GO:0006260) |
| 0.1 | 0.7 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
| 0.1 | 0.9 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.5 |